Neuropeptide Y (NPY) Y2 receptor-selective agonist inhibits food intake and promotes fat metabolism in mice: Combined anorectic effects of Y2 and Y4 receptor-selective agonists

Peptides

Volumn 28, Issue 2, 2007, Pages 235-240

  Balasubramaniam, Ambikaipakan ^a,b   Joshi, Rashika ^a,b   Su, Chunhua ^a,b   Friend, Lou Ann ^a,b   James, J Howard ^a,b  

^a UNIVERSITY OF CINCINNATI MEDICAL CENTER   (United States)

^b SHRINERS HOSPITALS FOR CHILDREN   (United States)

Author keywords

Food intake; Metabolism; NPY; Obesity; PP; PYY; Y2 agonist; Y4 agonist

Indexed keywords

ANOREXIGENIC AGENT; BT 48; BVD 74D; LONG ACTING DRUG; NEUROPEPTIDE Y RECEPTOR AGONIST; NEUROPEPTIDE Y2 RECEPTOR; NEUROPEPTIDE Y4 RECEPTOR; PANCREAS POLYPEPTIDE; PEPTIDE YY; PEPTIDE YY [3-36]; UNCLASSIFIED DRUG;

ANIMAL EXPERIMENT; ANOREXIA; ARTICLE; CALORIC RESTRICTION; CONTROLLED STUDY; DOSE RESPONSE; DRUG ACTIVITY; DRUG DOSE COMPARISON; DRUG POTENTIATION; DRUG RECEPTOR BINDING; DRUG SELECTIVITY; FOOD INTAKE; LIGHT DARK CYCLE; LIPID METABOLISM; MALE; MOUSE; NONHUMAN; PRIORITY JOURNAL; RECEPTOR AFFINITY; RESPIRATORY QUOTIENT; WEIGHT GAIN;

ADIPOSE TISSUE; ANIMALS; APPETITE DEPRESSANTS; FEEDING BEHAVIOR; MALE; MICE; RECEPTORS, NEUROPEPTIDE Y;

MUS; RODENTIA;

EID: 33846637920     PISSN: 01969781     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.peptides.2006.08.041     Document Type: Article

References (35)

1. Adrian T.E., Ferri G.L., Bacarese-Hamilton A.J., Fuessl H.S., Polak J.M., and Bloom S.R. Human distribution and release of a putative new gut hormone, peptide YY. Gastroenterology 89 (1985) 1070-1077
2. Adrian T.E., Greenberg G.R., Besterman H.S., and Bloom S.R. Pharmacokinetics of pancreatic polypeptide in man. Gut 19 (1978) 907-909
3. Asakawa A., Inui A., Yuzuriha H., Ueno N., Katsuura G., Fujimiya M., et al. Characterization of the effects of pancreatic polypeptide in the regulation of energy balance. Gastroenterology 124 (2003) 1325-1336
4. Balasubramaniam A. Neuropeptide Y (NPY) family of hormones: progress in the development of receptor selective agonists and antagonists. Curr Pharm Des 9 (2003) 1165-1175
5. Balasubramaniam A., Mullins D.E., Lin S., Zhai W., Tao Z., Dhawan V.C., et al. Neuropeptide Y (NPY) Y4 receptor selective agonists based on NPY(32-36): development of an anorectic Y4 receptor selective agonist with picomolar affinity. J Med Chem 49 (2006) 2661-2665
6. Balasubramaniam A., Tao Z., Zhai W., Stein M., Sheriff S., Chance W.T., et al. Structure-activity studies including a Psi(CH(2)-NH) scan of peptide YY (PYY) active site, PYY(22-36), for interaction with rat intestinal PYY receptors: development of analogues with potent in vivo activity in the intestine. J Med Chem 43 (2000) 3420-3427
7. Batterham R.L., Cohen M.A., Ellis S.M., le Roux C.W., Withers D.J., Frost G.S., et al. Inhibition of food intake in obese subjects by peptide YY3-36. N Engl J Med 349 (2003) 941-948
8. Batterham R.L., Cowley M.A., Small C.J., Herzog H., Cohen M.A., Dakin C.L., et al. Gut hormone PYY(3-36) physiologically inhibits food intake. Nature 418 (2002) 650-654
9. Batterham R.L., le Roux C.W., Cohen M.A., Park A.J., Ellis S.M., Patterson M., et al. Pancreatic polypeptide reduces appetite and food intake in humans. J Clin Endocrinol Metab 88 (2003) 3989-3992
10. Bell D., Allen A.R., Kelso E.J., Balasubramaniam A., and McDermott B.J. Induction of hypertrophic responsiveness of cardiomyocytes to neuropeptide Y in response to pressure overload. J Pharmacol Exp Ther 303 (2002) 581-591
11. Chance W.T., Nelson J.L., Kim M., Foley-Nelson T., Chen M.H., and Fischer J.E. Burn-induced alterations in feeding, energy expenditure, and brain amine neurotransmitters in rats. J Trauma 27 (1987) 503-509
12. Clark J.T., Kalra P.S., Crowley W.R., and Kalra S.P. Neuropeptide Y and human pancreatic polypeptide stimulate feeding behavior in rats. Endocrinology 115 (1984) 427-429
13. Dhillo W.S., Small C.J., Stanley S.A., Jethwa P.H., Seal L.J., Murphy K.G., et al. Hypothalamic interactions between neuropeptide Y, agouti-related protein, cocaine- and amphetamine-regulated transcript and alpha-melanocyte-stimulating hormone in vitro in male rats. J Neuroendocrinol 14 (2002) 725-730
14. Eberlein G.A., Eysselein V.E., Schaeffer M., Layer P., Grandt D., Goebell H., et al. A new molecular form of PYY: structural characterization of human PYY(3-36) and PYY(1-36). Peptides 10 (1989) 797-803
15. Hanusch-Enserer U., and Roden M. News in gut-brain communication: a role of peptide YY (PYY) in human obesity and following bariatric surgery?. Eur J Clin Invest 35 (2005) 425-430
16. Henry M., Ghibaudi L., Gao J., and Hwa J.J. Energy metabolic profile of mice after chronic activation of central NPY Y1, Y2, or Y5 receptors. Obes Res 13 (2005) 36-47
17. Herzog H. Neuropeptide Y and energy homeostasis: insights from Y receptor knockout models. Eur J Pharmacol 480 (2003) 21-29
18. Holm V.A. The diagnosis of Prader-Willi Syndrome. In: Holm V.A., Sulzbacher S.J., and Pipes P.L. (Eds). Prader-Willi Syndrome (1979), University Park Press, Baltimore 27-45
19. Hwa J.J., Witten M.B., Williams P., Ghibaudi L., Gao J., Salisbury B.G., et al. Activation of the NPY Y5 receptor regulates both feeding and energy expenditure. Am J Physiol 277 (1999) R1428-R1434
20. Katsuura G., Asakawa A., and Inui A. Roles of pancreatic polypeptide in regulation of food intake. Peptides 23 (2002) 323-329
21. Lazarus NR, inventor; Burroughs Wellcome Co., assignee. Biologically active amides. US patent 4355025. 1982 October 19.
22. Litvak D.A., Iseki H., Evers B.M., Greeley Jr. G.H., Hellmich M.R., Iwase K., et al. Characterization of two novel proabsorptive peptide YY analogs, BIM-43073D and BIM-43004C. Dig Dis Sci 44 (1999) 643-648
23. Malaisse-Lagae F., Carpentier J.L., Patel Y.C., Malaisse W.J., and Orci L. Pancreatic polypeptide: a possible role in the regulation of food intake in the mouse. Hypothesis. Experientia 33 (1977) 915-917
24. Morley J.E., and Flood J.F. An investigation of tolerance to the actions of leptogenic and anorexigenic drugs in mice. Life Sci 41 (1987) 2157-2165
25. Naveilhan P., Hassani H., Canals J.M., Ekstrand A.J., Larefalk A., Chhajlani V., et al. Normal feeding behavior, body weight and leptin response require the neuropeptide Y Y2 receptor. Nat Med 5 (1999) 1188-1193
26. Parker E., Van Heek M., and Stamford A. Neuropeptide Y receptors as targets for anti-obesity drug development: perspective and current status. Eur J Pharmacol 440 (2002) 173-187
27. Pellieux C., Sauthier T., Domenighetti A., Marsh D.J., Palmiter R.D., Brunner H.R., et al. Neuropeptide Y (NPY) potentiates phenylephrine-induced mitogen-activated protein kinase activation in primary cardiomyocytes via NPY Y5 receptors. Proc Natl Acad Sci USA 97 (2000) 1595-1600
28. Pittner R.A., Moore C.X., Bhavsar S.P., Gedulin B.R., Smith P.A., Jodka C.M., et al. Effects of PYY[3-36] in rodent models of diabetes and obesity. Int J Obes Relat Metab Disord 28 (2004) 963-971
29. Renshaw D., and Batterham R.L. Peptide YY: a potential therapy for obesity. Curr Drug Targets 6 (2005) 171-179
30. Shechter Y., Tsubery H., Mironchik M., Rubinstein M., and Fridkin M. Reversible PEGylation of peptide YY3-36 prolongs its inhibition of food intake in mice. FEBS Lett 579 (2005) 2439-2444
31. Small C.J., and Bloom S.R. The therapeutic potential of gut hormone peptide YY3-36 in the treatment of obesity. Expert Opin Investig Drugs 14 (2005) 647-653
32. Strader A.D., Vahl T.P., Jandacek R.J., Woods S.C., D'Alessio D.A., and Seeley R.J. Weight loss through ileal transposition is accompanied by increased ileal hormone secretion and synthesis in rats. Am J Physiol Endocrinol Metab 288 (2005) E447-E453
33. Talsania T., Anini Y., Siu S., Drucker D.J., and Brubaker P.L. Peripheral exendin-4 and peptide YY(3-36) synergistically reduce food intake through different mechanisms in mice. Endocrinology 146 (2005) 3748-3756
34. Tschop M., Castaneda T.R., Joost H.G., Thone-Reineke C., Ortmann S., Klaus S., et al. Physiology: does gut hormone PYY3-36 decrease food intake in rodents?. Nature 430 (2004) 1
35. Whitcomb D.C., Puccio A.M., Vigna S.R., Taylor I.L., and Hoffman G.E. Distribution of pancreatic polypeptide receptors in the rat brain. Brain Res 760 (1997) 137-149